# MEDI-557 Adult Dosing

> **NCT01562938** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 42 (actual)

## Conditions studied

- Respiratory Syncytial Virus

## Interventions

- **DRUG:** Placebo
- **DRUG:** MEDI-557
- **DRUG:** MEDI-557

## Key facts

- **NCT ID:** NCT01562938
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562938, "MEDI-557 Adult Dosing". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT01562938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*